Submissions for variant NM_024422.6(DSC2):c.2516A>G (p.Tyr839Cys)

dbSNP: rs2144781456

Total submissions: 5

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario	RCV001799097	SCV002043572	uncertain significance	Cardiomyopathy	2021-04-26	criteria provided, single submitter	clinical testing
Invitae	RCV001882576	SCV002169092	uncertain significance	Arrhythmogenic right ventricular dysplasia 11	2024-01-08	criteria provided, single submitter	clinical testing	This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 839 of the DSC2 protein (p.Tyr839Cys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DSC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1174704). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen	RCV001528530	SCV001740398	uncertain significance	not provided		no assertion criteria provided	clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+	RCV001528530	SCV001951206	uncertain significance	not provided		no assertion criteria provided	clinical testing
Clinical Genetics, Academic Medical Center	RCV001528530	SCV002034403	uncertain significance	not provided		no assertion criteria provided	clinical testing